Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.05) per share. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year.
South Jersey Indus Q3 EPS $(0.18) Down From $(0.17) YoY, Sales $608.52M Up From $365.63M YoY
South Jersey Indus (NYSE:SJI) reported quarterly losses of $(0.18) per share. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year. The company reported $608.52 million in
